Patent Assignment
Reel/Frame 037455/0436
Release of Security Interest
Recorded: 2016-01-11
Pages: 7
Assignor
KREOS CAPITAL IV (UK) LIMITED
Executed: 2015-10-09
Assignee
NABRIVA THERAPEUTICS AG
LEBERSTRASSE 20, WIEN, 1110, AUSTRIA
Covered Properties
(9)
Mutilin Derivatives and Their Use as Antibacterials
Patent:
6,784,193 →
Application:
10/048,438 →
Pleuromutilin Derivatives Having Antibacterial Activity
Antibacterial Mutilins
Use of Pleuromutilins for the Treatment of Disorders Caused by Helicobacter Pylori
Pleuromutilin Derivatives as Antimicrobials
Mutilin Derivatives and Their Use as Antibacterials
Antibacterial Mutilins
Tuberculosis Treatment Using Pleuromutilin Derivatives
Tuberculosis treatment using pleuromutilin derivatives
Application:
13/317,666 →
Publication:
US 2012/0046276
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0040 →
Assignment of Assignor's Interest
May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0007 →
Assignment of Assignor's Interest
Jan 17, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018783/0780 →
Assignment of Assignor's Interest
Feb 22, 2007
From: ASCHER, GERD; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018931/0846 →
Assignment of Assignor's Interest
Mar 1, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 018955/0941 →
Assignment of Assignor's Interest
Mar 20, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019046/0854 →
Assignment of Assignor's Interest
Mar 21, 2007
From: BERNER, HEINZ; KERBER, GABRIELE
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019049/0959 →
Change of Name
Apr 6, 2007
From: BIOCHEMIE GESELLSCHAFT M.B.H. (AKA BIOCHEMIE GMBH)
To: SANDOZ GMBH
Reel/Frame 019132/0047 →
Assignment of Assignor's Interest
Jun 13, 2007
From: ASCHER, GERD; BERNER, HEINZ; MANG, ROSEMARIE
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019479/0230 →
Change of Name
Aug 11, 2008
From: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021371/0769 →
Assignment of Assignor's Interest
Aug 13, 2008
From: SANDOZ GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021380/0209 →
Assignment of Assignor's Interest
Jun 28, 2012
From: ASCHER, GERD; STAUFFER, FRIEDRICH; BERNER, HEINZ; RIEDL, ROSEMARIE
To: NABRIVA THERAPEUTICS AG
Reel/Frame 028461/0245 →
Security Interest
Aug 28, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033647/0657 →
Entity Conversion
Sep 28, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047160/0234 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest
Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →